In 2014, the company cooperated with the famous Dutch enterprise CuraMedical B.V. and the Curacel series of global leading-edge hemostatic products have been successfully introduced into China.
On July 1, 2014, both parties signed the agreement of authorizing the company as exclusive agent of China for oxidized regenerated cellulose hemostat .Company Chairman Shen Hao, General Manager Hu Jinyuan, CuraMedical B.V. CEO Fred J. Hoogland attended the signing ceremony in Guangzhou.